Repetitive transcranial magnetic stimulation to treat benign epilepsy with centrotemporal spikes

Brain Stimul. 2022 May-Jun;15(3):601-604. doi: 10.1016/j.brs.2022.04.003. Epub 2022 Apr 12.

Abstract

Objectives: To investigate the effects of low-frequency repetitive transcranial magnetic stimulation (rTMS) on patients with benign epilepsy with centrotemporal spikes (BECTS).

Methods: In this open pilot study, we enrolled four BECTS patients who had frequent seizures (at least 3 seizures during the 3-month baseline). After localizing sources of interictal epileptiform discharges (IEDs) with magnetoencephalography, IEDs-source-rTMS (1 Hz) with 500 pulses at 90% of resting motor threshold was applied for 10 weekdays in each patient. The primary outcome measure was the seizure-reduction rate after rTMS. Other outcome measures were the spike-wave index (SWI), behavioral evaluation, and adverse effects.

Results: All four patients received at least 3 months seizure-free after rTMS. Compared with baseline, SWI decreased significantly after rTMS in three patients (patient 1, 3 and 4) (P = .002, P = .007, and P < .001, respectively). Attention deficit identified in two patients in baseline recovered to the normal range after rTMS. No adverse effect was observed.

Discussion: Our preliminary observation provides a promising approach to reducing clinical seizures for BECTS with frequent seizures. Of importance, our data may provide a potentially novel method for the high prevalence of behavioral problems in BECTS patients via decreasing cortical hyperexcitability.

Keywords: Benign epilepsy with centrotemporal spikes; Electroencephalogram; Epilepsy; Neuromodulation; Repetitive transcranial magnetic stimulation.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Electroencephalography / methods
  • Epilepsy, Rolandic* / therapy
  • Humans
  • Pilot Projects
  • Seizures / therapy
  • Transcranial Magnetic Stimulation / adverse effects
  • Transcranial Magnetic Stimulation / methods